IMS Health agreed to let Holland's VNU N.V. cancel its $7 billion acquisition of it, as a majority of VNU shareholders opposed the deal. IMS Health in response said its board has approved the buyback of 10 million more shares, on top of its existing plan that still allows for 4.4 million shares to be bought back. |